Lok AS - Search Results

1

Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?

Zoulim F, Buti M, Lok AS. Zoulim F, et al. Among authors: lok as. J Viral Hepat. 2007 Nov;14 Suppl 1:29-36. doi: 10.1111/j.1365-2893.2007.00915.x. J Viral Hepat. 2007. PMID: 17958640 Free article. Review.

2

Hepatitis B virus infection.

Trépo C, Chan HL, Lok A. Trépo C, et al. Lancet. 2014 Dec 6;384(9959):2053-63. doi: 10.1016/S0140-6736(14)60220-8. Epub 2014 Jun 18. Lancet. 2014. PMID: 24954675 Review.

3

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.

Bourlière M, Gordon SC, Flamm SL, Cooper CL, Ramji A, Tong M, Ravendhran N, Vierling JM, Tran TT, Pianko S, Bansal MB, de Lédinghen V, Hyland RH, Stamm LM, Dvory-Sobol H, Svarovskaia E, Zhang J, Huang KC, Subramanian GM, Brainard DM, McHutchison JG, Verna EC, Buggisch P, Landis CS, Younes ZH, Curry MP, Strasser SI, Schiff ER, Reddy KR, Manns MP, Kowdley KV, Zeuzem S; POLARIS-1 and POLARIS-4 Investigators. Bourlière M, et al. N Engl J Med. 2017 Jun 1;376(22):2134-2146. doi: 10.1056/NEJMoa1613512. N Engl J Med. 2017. PMID: 28564569 Free article. Clinical Trial.

4

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference.

Cornberg M, Lok AS, Terrault NA, Zoulim F; 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Cornberg M, et al. Among authors: lok as. Hepatology. 2019 Nov 12. doi: 10.1002/hep.31030. Online ahead of print. Hepatology. 2019. PMID: 31713892

5

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference^‡.

Cornberg M, Lok AS, Terrault NA, Zoulim F; 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Cornberg M, et al. Among authors: lok as. J Hepatol. 2020 Mar;72(3):539-557. doi: 10.1016/j.jhep.2019.11.003. Epub 2019 Nov 12. J Hepatol. 2020. PMID: 31730789 Free article. Review.

6

Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study.

Lee WM, King WC, Janssen HLA, Ghany MG, Fontana RJ, Fried M, Sterling RK, Feld JJ, Wang J, Mogul DB, Cooper SL, Bisceglie AMD; Hepatitis B Research Network (HBRN). Lee WM, et al. J Viral Hepat. 2021 Nov;28(11):1526-1538. doi: 10.1111/jvh.13591. Epub 2021 Aug 11. J Viral Hepat. 2021. PMID: 34355475 Free PMC article.

7

The scientific basis of combination therapy for chronic hepatitis B functional cure.

Lim SG, Baumert TF, Boni C, Gane E, Levrero M, Lok AS, Maini MK, Terrault NA, Zoulim F. Lim SG, et al. Among authors: lok as. Nat Rev Gastroenterol Hepatol. 2023 Apr;20(4):238-253. doi: 10.1038/s41575-022-00724-5. Epub 2023 Jan 11. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36631717 Review.

8

Antiviral therapy for chronic hepatitis B.

Jafri SM, Lok AS. Jafri SM, et al. Among authors: lok as. Clin Liver Dis. 2010 Aug;14(3):425-38. doi: 10.1016/j.cld.2010.05.005. Clin Liver Dis. 2010. PMID: 20638023 Review.

9

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

Lok AS. Lok AS. J Gastroenterol Hepatol. 2011 Feb;26(2):221-7. doi: 10.1111/j.1440-1746.2010.06576.x. J Gastroenterol Hepatol. 2011. PMID: 21070361

10

Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region.

Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, Schinazi RF. Stuyver LJ, et al. Hepatology. 2001 Mar;33(3):751-7. doi: 10.1053/jhep.2001.22166. Hepatology. 2001. PMID: 11230757 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

624 results

Search Page